FDA Approves Gallium Ga-68 Gozetotide for Diagnostic Use
The FDA has approved the application ANDA219189 for Gallium Ga-68 Gozetotide, submitted by IONETIX.
Asset / Drug
Drug and asset intelligence for IONETIX with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.